These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 19222175

  • 1. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
    Paulitschke V, Kunstfeld R, Mohr T, Slany A, Micksche M, Drach J, Zielinski C, Pehamberger H, Gerner C.
    J Proteome Res; 2009 May; 8(5):2501-10. PubMed ID: 19222175
    [Abstract] [Full Text] [Related]

  • 2. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum.
    Piersma SR, Fiedler U, Span S, Lingnau A, Pham TV, Hoffmann S, Kubbutat MH, Jiménez CR.
    J Proteome Res; 2010 Apr 05; 9(4):1913-22. PubMed ID: 20085282
    [Abstract] [Full Text] [Related]

  • 3. Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B.
    Slany A, Haudek VJ, Zwickl H, Gundacker NC, Grusch M, Weiss TS, Seir K, Rodgarkia-Dara C, Hellerbrand C, Gerner C.
    J Proteome Res; 2010 Jan 05; 9(1):6-21. PubMed ID: 19678649
    [Abstract] [Full Text] [Related]

  • 4. Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells.
    Wimmer H, Gundacker NC, Griss J, Haudek VJ, Stättner S, Mohr T, Zwickl H, Paulitschke V, Baron DM, Trittner W, Kubicek M, Bayer E, Slany A, Gerner C.
    Electrophoresis; 2009 Jun 05; 30(12):2076-89. PubMed ID: 19582709
    [Abstract] [Full Text] [Related]

  • 5. A novel technique to specifically analyze the secretome of cells and tissues.
    Zwickl H, Traxler E, Staettner S, Parzefall W, Grasl-Kraupp B, Karner J, Schulte-Hermann R, Gerner C.
    Electrophoresis; 2005 Jul 05; 26(14):2779-85. PubMed ID: 15966010
    [Abstract] [Full Text] [Related]

  • 6. Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.
    Zuidervaart W, Hensbergen PJ, Wong MC, Deelder AM, Tensen CP, Jager MJ, Gruis NA.
    Invest Ophthalmol Vis Sci; 2006 Mar 05; 47(3):786-93. PubMed ID: 16505008
    [Abstract] [Full Text] [Related]

  • 7. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
    Yocum AK, Busch CM, Felix CA, Blair IA.
    J Proteome Res; 2006 Oct 05; 5(10):2743-53. PubMed ID: 17022645
    [Abstract] [Full Text] [Related]

  • 8. The cell line secretome, a suitable tool for investigating proteins released in vivo by tumors: application to the study of p53-modulated proteins secreted in lung cancer cells.
    Chenau J, Michelland S, de Fraipont F, Josserand V, Coll JL, Favrot MC, Seve M.
    J Proteome Res; 2009 Oct 05; 8(10):4579-91. PubMed ID: 19639960
    [Abstract] [Full Text] [Related]

  • 9. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR, Zhang H, Zhao L, Wang P, Kelly-Spratt KS, Ivey RG, Piening BD, Feng LC, Kasarda E, Gurley KE, Eng JK, Chodosh LA, Kemp CJ, McIntosh MW, Paulovich AG.
    J Proteome Res; 2007 Oct 05; 6(10):3962-75. PubMed ID: 17711321
    [Abstract] [Full Text] [Related]

  • 10. Scanning the cell surface proteome of cancer cells and identification of metastasis-associated proteins using a subtractive immunization strategy.
    Rasmussen N, Ditzel HJ.
    J Proteome Res; 2009 Nov 05; 8(11):5048-59. PubMed ID: 19764822
    [Abstract] [Full Text] [Related]

  • 11. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G, Jung K, Stephan C, Diamandis EP.
    J Proteome Res; 2008 Aug 05; 7(8):3329-38. PubMed ID: 18578523
    [Abstract] [Full Text] [Related]

  • 12. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K, Yu K, Kesuma D, Hooi M, Huang N, Chen W, Lee SY, Goh XP, Tan LK, Liu J, Soon SY, Bin Abdul Rashid S, Putti TC, Jikuya H, Ichikawa T, Nishimura O, Salto-Tellez M, Tan P.
    J Proteome Res; 2008 Apr 05; 7(4):1518-28. PubMed ID: 18318472
    [Abstract] [Full Text] [Related]

  • 13. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
    He Y, Wu X, Liu X, Yan G, Xu C.
    J Proteome Res; 2010 Dec 03; 9(12):6180-90. PubMed ID: 21028892
    [Abstract] [Full Text] [Related]

  • 14. Comparative proteomic analysis of matched primary and metastatic melanoma cell lines.
    Al-Ghoul M, Brück TB, Lauer-Fields JL, Asirvatham VS, Zapata C, Kerr RG, Fields GB.
    J Proteome Res; 2008 Sep 03; 7(9):4107-18. PubMed ID: 18698805
    [Abstract] [Full Text] [Related]

  • 15. Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation.
    Sarvaiya HA, Yoon JH, Lazar IM.
    Rapid Commun Mass Spectrom; 2006 Sep 03; 20(20):3039-55. PubMed ID: 16986208
    [Abstract] [Full Text] [Related]

  • 16. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P, Roumeliotis T, Hrstka R, Nenutil R, Vojtesek B, Garbis SD.
    J Proteome Res; 2009 Jan 03; 8(1):362-73. PubMed ID: 19053527
    [Abstract] [Full Text] [Related]

  • 17. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS.
    Pardo M, García A, Thomas B, Piñeiro A, Akoulitchev A, Dwek RA, Zitzmann N.
    Proteomics; 2005 Dec 03; 5(18):4980-93. PubMed ID: 16267820
    [Abstract] [Full Text] [Related]

  • 18. Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage.
    Baruthio F, Quadroni M, Rüegg C, Mariotti A.
    Proteomics; 2008 Nov 03; 8(22):4733-47. PubMed ID: 18942674
    [Abstract] [Full Text] [Related]

  • 19. Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints.
    Escobar MA, Hoelz DJ, Sandoval JA, Hickey RJ, Grosfeld JL, Malkas LH.
    J Pediatr Surg; 2005 Feb 03; 40(2):349-58. PubMed ID: 15750928
    [Abstract] [Full Text] [Related]

  • 20. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A, Ma PC, Salgia R.
    Mass Spectrom Rev; 2007 Feb 03; 26(3):451-66. PubMed ID: 17407130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.